Aquestive Therapeutics, Inc.
NASDAQ:AQST
5.2 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 23.872 | 27.273 | 28.024 | 31.807 | 49.326 | 60.599 | 17.379 | 9.209 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 23.872 | 27.273 | 28.024 | 31.807 | 49.326 | 60.599 | 17.379 | 9.209 |
| Net Receivables
| 8.471 | 4.704 | 12.12 | 6.955 | 13.13 | 6.481 | 6.179 | 10.817 |
| Inventory
| 6.769 | 5.78 | 4.038 | 2.461 | 2.859 | 5.441 | 4.014 | 2.886 |
| Other Current Assets
| 1.854 | 2.131 | 3.077 | 3.402 | 2.999 | 1.68 | 0.06 | 0.059 |
| Total Current Assets
| 40.966 | 39.888 | 47.259 | 44.625 | 68.314 | 74.201 | 28.163 | 23.332 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 9.736 | 7.901 | 7.78 | 10.321 | 9.726 | 12.207 | 13.46 | 15.122 |
| Goodwill
| 0 | 0 | 0 | 0 | 0.286 | 0 | 0 | 0 |
| Intangible Assets
| 1.278 | 1.435 | 0.051 | 0.102 | 0.153 | 0.204 | 0.254 | 0.305 |
| Goodwill and Intangible Assets
| 1.278 | 1.435 | 0.051 | 0.102 | 0.439 | 0.204 | 0.254 | 0.305 |
| Long Term Investments
| 4 | 5 | 6 | 7 | 0 | 0 | 0 | 0 |
| Tax Assets
| -0 | -5 | -6 | -7 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 1.438 | 6.451 | 6.903 | 7.836 | 0 | 0.239 | 1.239 | 0.63 |
| Total Non-Current Assets
| 16.452 | 15.787 | 14.734 | 18.259 | 10.165 | 12.65 | 14.953 | 16.057 |
| Total Assets
| 57.418 | 55.675 | 61.993 | 62.884 | 78.479 | 86.851 | 43.116 | 39.389 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 8.926 | 9.946 | 8.314 | 7.089 | 12.274 | 20.436 | 9.601 | 6.638 |
| Short Term Debt
| 2.347 | 19.106 | 2.924 | 3.303 | 0 | 4.6 | 0.34 | 0 |
| Tax Payables
| 0.337 | 0.322 | 0.349 | 0.316 | 0.3 | 2.903 | 0.34 | 0 |
| Deferred Revenue
| 1.551 | 1.513 | 0.765 | 0.693 | 0.806 | 0.721 | 1.347 | 0.802 |
| Other Current Liabilities
| 5.484 | 9.114 | 9.961 | 10.019 | 5.475 | 7.195 | 4.062 | 3.366 |
| Total Current Liabilities
| 18.308 | 39.679 | 21.964 | 21.104 | 18.555 | 32.952 | 15.35 | 10.806 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 91.076 | 36.987 | 53.497 | 37.175 | 60.338 | 42.603 | 45.507 | 38.65 |
| Deferred Revenue Non-Current
| 32.345 | 31.417 | 7.122 | 3.633 | 4.348 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 5.399 | 0 | 59.059 | 47.524 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 16.777 | 66.146 | 2.485 | 1.945 | 1.36 | 1.216 | 8.754 | 7.509 |
| Total Non-Current Liabilities
| 145.597 | 134.55 | 122.163 | 90.277 | 66.046 | 43.819 | 54.261 | 46.159 |
| Total Liabilities
| 163.905 | 174.229 | 144.127 | 111.381 | 84.601 | 76.771 | 69.611 | 56.965 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 80.871 | 78.391 |
| Common Stock
| 0.069 | 0.055 | 0.041 | 0.035 | 0.034 | 0.025 | 12.727 | 11.243 |
| Retained Earnings
| -319.077 | -311.207 | -256.796 | -186.257 | -130.474 | -61.376 | -120.093 | -108.67 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 0 | 0 | 0 | -35.191 | -32.005 | -28.255 |
| Other Total Stockholders Equity
| 212.521 | 192.598 | 174.621 | 137.725 | 124.318 | 106.622 | 32.005 | 29.715 |
| Total Shareholders Equity
| -106.487 | -118.554 | -82.134 | -48.497 | -6.122 | 10.08 | -26.495 | -17.576 |
| Total Equity
| -106.487 | -118.554 | -82.134 | -48.497 | -6.122 | 10.08 | -26.495 | -17.576 |
| Total Liabilities & Shareholders Equity
| 57.418 | 55.675 | 61.993 | 62.884 | 78.479 | 86.851 | 43.116 | 39.389 |